Atlas Trials

The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients

Clinical trial NCT03140657 · COMPLETED

Trial details

NCT number
NCT03140657
Sponsor
Tabriz University of Medical Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2017-04-29
Primary completion
2017-11-07
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.